201 related articles for article (PubMed ID: 9225278)
1. Differential distribution of [3H]sumatriptan binding sites (5-HT1B, 5-HT1D and 5-HT1F receptors) in human brain: focus on brainstem and spinal cord.
Castro ME; Pascual J; Romón T; del Arco C; del Olmo E; Pazos A
Neuropharmacology; 1997; 36(4-5):535-42. PubMed ID: 9225278
[TBL] [Abstract][Full Text] [Related]
2. Autoradiographic mapping of [3H]sumatriptan binding in cat brain stem and spinal cord.
Mills A; Martin GR
Eur J Pharmacol; 1995 Jul; 280(2):175-8. PubMed ID: 7589183
[TBL] [Abstract][Full Text] [Related]
3. [3H]sumatriptan labels both 5-HT1D and 5-HT1F receptor binding sites in the guinea pig brain: an autoradiographic study.
Waeber C; Moskowitz MA
Naunyn Schmiedebergs Arch Pharmacol; 1995 Sep; 352(3):263-75. PubMed ID: 8584041
[TBL] [Abstract][Full Text] [Related]
4. Evidence for presynaptic location of inhibitory 5-HT1D beta-like autoreceptors in the guinea-pig brain cortex.
Bühlen M; Fink K; Böing C; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):281-9. PubMed ID: 8692282
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of noradrenaline release via presynaptic 5-HT1D alpha receptors in human atrium.
Molderings GJ; Frölich D; Likungu J; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):272-80. PubMed ID: 8692281
[TBL] [Abstract][Full Text] [Related]
6. Magnitude of 5-HT1B and 5-HT1A receptor activation in guinea-pig and rat brain: evidence from sumatriptan dimer-mediated [35S]GTPgammaS binding responses.
Dupuis DS; Perez M; Halazy S; Colpaert FC; Pauwels PJ
Brain Res Mol Brain Res; 1999 Apr; 67(1):107-23. PubMed ID: 10101238
[TBL] [Abstract][Full Text] [Related]
7. [3H]Sumatriptan binding sites in human brain: regional-dependent labelling of 5-HT1D and 5-HT1F receptors.
Pascual J; Del Arco C; Romón T; Del Olmo E; Pazos A
Eur J Pharmacol; 1996 Jan; 295(2-3):271-4. PubMed ID: 8720594
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of the 5-HT receptor binding profile of eletriptan and kinetics of [3H]eletriptan binding at human 5-HT1B and 5-HT1D receptors.
Napier C; Stewart M; Melrose H; Hopkins B; McHarg A; Wallis R
Eur J Pharmacol; 1999 Mar; 368(2-3):259-68. PubMed ID: 10193663
[TBL] [Abstract][Full Text] [Related]
9. Autoradiographic characterisation and localisation of 5-HT1D compared to 5-HT1B binding sites in rat brain.
Bruinvels AT; Palacios JM; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 1993 Jun; 347(6):569-82. PubMed ID: 8361548
[TBL] [Abstract][Full Text] [Related]
10. The 5-HT1D receptor antagonist GR-127,935 prevents inhibitory effects of sumatriptan but not CP-122,288 and 5-CT on neurogenic plasma extravasation within guinea pig dura mater.
Yu XJ; Cutrer FM; Moskowitz MA; Waeber C
Neuropharmacology; 1997 Jan; 36(1):83-91. PubMed ID: 9144644
[TBL] [Abstract][Full Text] [Related]
11. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
Ellwood AJ; Curtis MJ
Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
[TBL] [Abstract][Full Text] [Related]
12. Characterization of human serotonin 1D and 1B receptors using [3H]-GR-125743, a novel radiolabelled serotonin 5HT1D/1B receptor antagonist.
Doménech T; Beleta J; Palacios JM
Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):328-34. PubMed ID: 9303569
[TBL] [Abstract][Full Text] [Related]
13. Autoradiographic visualisation of [3H]5-carboxamidotryptamine binding sites in the guinea pig and rat brain.
Waeber C; Moskowitz MA
Eur J Pharmacol; 1995 Sep; 283(1-3):31-46. PubMed ID: 7498319
[TBL] [Abstract][Full Text] [Related]
14. A comparative autoradiographic study of 5-HT1D binding sites in human and guinea-pig brain using different radioligands.
Bruinvels AT; Landwehrmeyer B; Probst A; Palacios JM; Hoyer D
Brain Res Mol Brain Res; 1994 Jan; 21(1-2):19-29. PubMed ID: 8164519
[TBL] [Abstract][Full Text] [Related]
15. Autoradiographic distribution of [3H]sumatriptan-binding sites in post-mortem human brain.
Pascual J; del Arco C; Romón T; del Olmo E; Castro E; Pazos A
Cephalalgia; 1996 Aug; 16(5):317-22. PubMed ID: 8869766
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques.
Nilsson T; Longmore J; Shaw D; Pantev E; Bard JA; Branchek T; Edvinsson L
Eur J Pharmacol; 1999 May; 372(1):49-56. PubMed ID: 10374714
[TBL] [Abstract][Full Text] [Related]
17. [3H]-5-carboxamidotryptamine labels 5-HT1D binding sites in bovine substantia nigra.
Nowak HP; Mahle CD; Yocca FD
Br J Pharmacol; 1993 Aug; 109(4):1206-11. PubMed ID: 8401931
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology of cloned human 5-HT1D receptor-mediated functional responses in stably transfected rat C6-glial cell lines: further evidence differentiating human 5-HT1D and 5-HT1B receptors.
Pauwels PJ; Palmier C; Wurch T; Colpaert FC
Naunyn Schmiedebergs Arch Pharmacol; 1996 Jan; 353(2):144-56. PubMed ID: 8717154
[TBL] [Abstract][Full Text] [Related]
19. Ketanserin-sensitive depressant actions of 5-HT receptor agonists in the neonatal rat spinal cord.
Manuel NA; Wallis DI; Crick H
Br J Pharmacol; 1995 Nov; 116(6):2647-54. PubMed ID: 8590984
[TBL] [Abstract][Full Text] [Related]
20. Autoradiographic mapping of 5-HT1B- and 5-HT1D receptors in human brain using [3H]alniditan, a new radioligand.
Bonaventure P; Schotte A; Cras P; Leysen JE
Recept Channels; 1997; 5(3-4):225-30. PubMed ID: 9606727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
